Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Treasury Shares: 2022-2024

Historic Treasury Shares for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Dec 2024 value amounting to $1.8 million.

  • Day One Biopharmaceuticals' Treasury Shares rose 46.17% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.8 million, marking a year-over-year increase of 46.17%. This contributed to the annual value of $1.8 million for FY2024, which is 86.89% up from last year.
  • Latest data reveals that Day One Biopharmaceuticals reported Treasury Shares of $1.8 million as of FY2024, which was up 86.89% from $949,370 recorded in FY2023.
  • In the past 5 years, Day One Biopharmaceuticals' Treasury Shares ranged from a high of $1.8 million in FY2024 and a low of $485,351 during FY2022.
  • Over the past 3 years, Day One Biopharmaceuticals' median Treasury Shares value was $949,370 (recorded in 2023), while the average stood at $1.1 million.
  • Data for Day One Biopharmaceuticals' Treasury Shares shows a peak YoY skyrocketed of 95.60% (in 2023) over the last 5 years.
  • Over the past 3 years, Day One Biopharmaceuticals' Treasury Shares (Yearly) stood at $485,351 in 2022, then surged by 95.60% to $949,370 in 2023, then skyrocketed by 86.89% to $1.8 million in 2024.